Literature DB >> 18992917

Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.

Brody Winn1, Rosemarie Tavares, Jacqueline Fanion, Lelia Noble, John Gao, Edmond Sabo, Murray B Resnick.   

Abstract

Undifferentiated or medullary carcinoma is characterized by its distinct histologic appearance and relatively better prognosis compared to poorly differentiated colonic carcinoma. These 2 entities may be difficult to differentiate by light microscopy alone. Only limited immunohistochemical studies investigating medullary carcinoma have been reported. These studies suggest a loss of intestinal differentiation, exemplified by a high percentage of CDX2 negativity. Our aim was to further characterize the immunohistochemical profile of medullary carcinoma, with particular emphasis on intestinal markers. Paraffin blocks from 16 cases of medullary carcinoma and 33 cases of poorly differentiated colonic carcinoma were retrieved, and tissue microarrays were constructed and stained with an immunohistochemical panel including CDX2, CK7, CK20, p53, intestinal trefoil factor 3, chromogranin, synaptophysin, MLH-1, MUC-1, MUC-2, and calretinin. A significantly higher proportion of medullary carcinomas, as opposed to poorly differentiated colonic carcinomas, showed loss of staining for MLH-1 and for the intestinal transcription factor CDX2, in accordance with previous studies. MLH-1 staining was present in only 21% of medullary carcinoma cases compared with 60% of the poorly differentiated colonic carcinoma cases (P = .02), whereas CDX2 was positive in 19% of medullary carcinomas and 55% of poorly differentiated colonic carcinomas (P = .03). Interestingly, calretinin staining was strongly positive in 73% of medullary carcinomas compared to only 12% of poorly differentiated colonic carcinomas (P < .0001). Evidence of intestinal differentiation by MUC-1, MUC-2, and TFF-3 staining was seen in 67%, 60%, and 53% of the medullary carcinomas, respectively. These 3 markers were frequently positive in many of the CDX2-negative medullary carcinoma cases. Medullary carcinoma of the colon retains a significant degree of intestinal differentiation as evidenced by its high percentage of staining for MUC-1, MUC-2, and TFF-3. Calretinin, MLH-1, and CDX2 may help to differentiate medullary carcinoma from poorly differentiated colonic carcinoma of the colon.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992917      PMCID: PMC2657293          DOI: 10.1016/j.humpath.2008.08.014

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  26 in total

1.  Improved prognosis of solid-type poorly differentiated colorectal adenocarcinoma: a clinicopathological and immunohistochemical study.

Authors:  Y Sugao; T Yao; C Kubo; M Tsuneyoshi
Journal:  Histopathology       Date:  1997-08       Impact factor: 5.087

2.  Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics.

Authors:  J Rüschoff; W Dietmaier; J Lüttges; G Seitz; T Bocker; H Zirngibl; J Schlegel; H K Schackert; K W Jauch; F Hofstaedter
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation.

Authors:  R Cargnello; M R Celio; B Schwaller; V Gotzos
Journal:  Biochim Biophys Acta       Date:  1996-10-11

4.  Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma.

Authors:  Mark R Wick; Jon L Vitsky; Jon H Ritter; Paul E Swanson; Stacey E Mills
Journal:  Am J Clin Pathol       Date:  2005-01       Impact factor: 2.493

5.  Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues.

Authors:  V Gotzos; E S Wintergerst; J P Musy; H P Spichtin; C Y Genton
Journal:  Am J Surg Pathol       Date:  1999-06       Impact factor: 6.394

6.  Cloning and chromosome assignment of the human CDX2 gene.

Authors:  F Drummond; W Putt; M Fox; Y H Edwards
Journal:  Ann Hum Genet       Date:  1997-09       Impact factor: 1.670

7.  Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases.

Authors:  J Jessurun; M Romero-Guadarrama; J C Manivel
Journal:  Hum Pathol       Date:  1999-07       Impact factor: 3.466

8.  Significance of MUC1 and MUC2 mucin expression in colorectal cancer.

Authors:  Y Ajioka; L J Allison; J R Jass
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

9.  Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types.

Authors:  M Blank; E Klussmann; S Krüger-Krasagakes; A Schmitt-Gräff; M Stolte; G Bornhoeft; H Stein; P X Xing; I F McKenzie; C P Verstijnen
Journal:  Int J Cancer       Date:  1994-11-01       Impact factor: 7.396

10.  Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas.

Authors:  M Miettinen
Journal:  Mod Pathol       Date:  1995-05       Impact factor: 7.842

View more
  23 in total

Review 1.  [Prognostic marker profiles for risk of distant metastases in colorectal cancer].

Authors:  J Neumann; S Reu; T Kirchner
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

2.  Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses.

Authors:  Naoki Asano; Akira Imatani; Tomohiro Watanabe; Jun Fushiya; Yutaka Kondo; Xiaoyi Jin; Nobuyuki Ara; Kaname Uno; Katsunori Iijima; Tomoyuki Koike; Warren Strober; Tooru Shimosegawa
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

3.  Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon.

Authors:  Soichiro Ishihara; Toshiaki Watanabe; Takuya Akahane; Ryu Shimada; Atsushi Horiuchi; Hajime Shibuya; Tamuro Hayama; Hideki Yamada; Keijiro Nozawa; Keiji Matsuda; Koutarou Maeda; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2011-11-04       Impact factor: 2.571

4.  Medullary carcinoma of the large intestine: a population based analysis.

Authors:  Pragatheeshwar Thirunavukarasu; Magesh Sathaiah; Smit Singla; Shyam Sukumar; Arivarasan Karunamurthy; Kothai Divya Pragatheeshwar; Kenneth K W Lee; Herbert Zeh; Kevin M Kane; David L Bartlett
Journal:  Int J Oncol       Date:  2010-10       Impact factor: 5.650

5.  Medullary carcinoma of the colon: can the undifferentiated be differentiated?

Authors:  Anne-Marie Kanstrup Fiehn; Morten Grauslund; Anders Glenthøj; Linea Cecilie Melchior; Ben Vainer; Gro Linno Willemoe
Journal:  Virchows Arch       Date:  2014-10-23       Impact factor: 4.064

Review 6.  Prognostic biomarkers in colorectal cancer: where do we stand?

Authors:  Xavier Sagaert
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 7.  Poorly differentiated medullary carcinoma of the colon with an unusual phenotypic profile mimicking high grade large cell lymphoma - a unique case report and review of the literature.

Authors:  Johnny Nguyen; Domenico Coppola; Yuan Shan; Ling Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

8.  Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.

Authors:  Abd AlRahman Mohammad Foda; Amira Kamal El-Hawary; Hazem Hamed
Journal:  Pathol Oncol Res       Date:  2016-04-09       Impact factor: 3.201

9.  Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.

Authors:  Ross J Taliano; Shaolei Lu; Kamaljeet Singh; Shamlal Mangray; Rose Tavares; Lelia Noble; Murray B Resnick; Evgeny Yakirevich
Journal:  Hum Pathol       Date:  2013-12       Impact factor: 3.466

10.  Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas.

Authors:  Brody Winn; Rosemarie Tavares; Andres Matoso; Lelia Noble; Jacqueline Fanion; Scott A Waldman; Murray B Resnick
Journal:  Hum Pathol       Date:  2009-10-01       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.